August 2, 2015: Due to a decline in the market, anti-obesity drugmaker VIVUS Inc. will trim some fat in order to remain competitive, the company announced.
August 3, 2015: Shire plc announced today that it bought New York-based Foresight Biotherapeutics Inc. for $300M. Foresight Biotherapeutics is a privately held company.
August 3, 2015: Isis and Astra inked a deal to develop antisense therapies for cardiovascular, metabolic and renal diseases, the companies jointly announced this morning. This marks a continued trend for Isis to collaborate with a large pharma company.
August 3, 2015: Glaxo announced today that it had re-hired Vivian Shi. Shi was formerly a GSK government affairs executive linked to an internal investigation.